Our previous work demonstrated that NQO1 can bind to pyruvate kinase L/R (PKLR), a key regulator of glycolytic reprogramming in breast cancer, thereby activating the AMPK and AKT/mTOR signaling pathways and inducing glycolytic reprogramming [10]. Here, NQO1 is linked to breast carcinoma.